Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 133

Results For "RNA"

2259 News Found

AIIA signs MoU with AIST
Policy | October 09, 2022

AIIA signs MoU with AIST

The MoU will enable both countries to promote research collaboration and building capacities in the field of the Indian Ayurvedic system of traditional medicines


Biocon Foundation receives Mahatma Award 2022
News | October 09, 2022

Biocon Foundation receives Mahatma Award 2022

The award was presented to Biocon Foundation as a mark of recognition of various projects undertaken during the year for reducing the environmental impact on cities


Dipharma receives regulatory authorization for the new line at Its cGMP pilot plant
Drug Approval | October 09, 2022

Dipharma receives regulatory authorization for the new line at Its cGMP pilot plant

The company increases its efficiency and is able to face the growing demand for its services.


Glenmark launches Lobeglitazone in India for Uncontrolled Type 2 Diabetes in adults
News | October 07, 2022

Glenmark launches Lobeglitazone in India for Uncontrolled Type 2 Diabetes in adults

Glenmark is the first company in India to launch Thiazolidinedione Lobeglitazone (0.5 mg).


L&T Construction bags order to construct manufacturing facility in Haryana
News | October 07, 2022

L&T Construction bags order to construct manufacturing facility in Haryana

This win is on the back of a prestigious order from Reliance Life Sciences


Medcare acquires 60% stake in Skin III
Healthcare | October 05, 2022

Medcare acquires 60% stake in Skin III

This acquisition will accelerate Medcare's plans to emerge as an international hub for health, beauty, and wellness adding to its existing network of 4 hospitals and over 20 medical centres in the UAE.


Wockhardt Hospitals, Mira Road starts a Comprehensive Clinic for Cancer Patients
Healthcare | October 05, 2022

Wockhardt Hospitals, Mira Road starts a Comprehensive Clinic for Cancer Patients

Specialized cancer care will be offered to cancer patients making it accessible and affordable. We have adopted a patient-centric approach.


Shionogi and MPP sign licence agreement for COVID-19 oral antiviral treatment
News | October 04, 2022

Shionogi and MPP sign licence agreement for COVID-19 oral antiviral treatment

Ensitrelvir is being evaluated for the treatment of COVID-19 to be administered as an oral tablet formulation taken once daily for five days.


Matt Sause elevated as new CEO of Roche Diagnostics
People | October 04, 2022

Matt Sause elevated as new CEO of Roche Diagnostics

Sause will become CEO Roche Diagnostics and a member of the Corporate Executive Committee effective 1 January 2023.